chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BLOOD CLOTS; This spontaneous report received from a patient concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose 1 total ,start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 2021, the subject experienced blood clots, and was hospitalized (date unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots leading to hospitalization was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: v0-20210530971-covid-19 vaccine ad26.cov2.s-Blood Clots. This event(s) is considered Un assessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
May 16, 2021 about 0400 diagnosed with Atrial Fibrillation, it stopped with medical intervention at 11am.  Symptoms were not feeling good, racing heart, no strength for the previous week.
Left thigh large red swelling and bruised, h/a, tired, neck stiffness.
patient was given vaccine at age 17 which is against recommendation for 18 years old for Moderna COVID vaccine. Patient did not have any side effects or unusual reaction after receiving 1st dose
The patient presented a few days after her 2nd Moderna vaccine with angioedema, S/P epinephrine IM x2, steroids, Benadryl. She had a similar presentation 1 month prior after her 1st Moderna vaccine as well, which also resulted in a hospitalization. She elected to get the vaccine again and subsequently came in with the same reaction.
A smaller rash started the day after I received the vaccine. about twelve hours later, the rash grew another 3 inches outward, I had been monitoring it with marker. it might continue to grow, or not.
had negative reaction to first moderna covid vaccination was cold shoulder; had negative reaction to first moderna covid vaccination was swelling from  shoulder to fingers of arm; had negative reaction to first Moderna covid vaccination was inability to move the fingers on the arm of the injection; Cough; This spontaneous case was reported by a patient and describes the occurrence of COUGH (Cough), PERIPHERAL COLDNESS (had negative reaction to first moderna covid vaccination was cold shoulder), PERIPHERAL SWELLING (had negative reaction to first moderna covid vaccination was swelling from  shoulder to fingers of arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (had negative reaction to first Moderna covid vaccination was inability to move the fingers on the arm of the injection) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ankylosing spondylitis.    Concurrent medical conditions included Ankylosing spondylitis.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. In February 2022, the patient experienced COUGH (Cough). On an unknown date, the patient experienced PERIPHERAL COLDNESS (had negative reaction to first moderna covid vaccination was cold shoulder), PERIPHERAL SWELLING (had negative reaction to first moderna covid vaccination was swelling from  shoulder to fingers of arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (had negative reaction to first Moderna covid vaccination was inability to move the fingers on the arm of the injection). In February 2022, COUGH (Cough) had resolved. At the time of the report, PERIPHERAL COLDNESS (had negative reaction to first moderna covid vaccination was cold shoulder), PERIPHERAL SWELLING (had negative reaction to first moderna covid vaccination was swelling from  shoulder to fingers of arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (had negative reaction to first Moderna covid vaccination was inability to move the fingers on the arm of the injection) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 test: (Negative) Negative.     The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Slightly sore arm the first day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 71-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 13:30 (Lot number: FE3590) at the age of 71 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (INFLUENZA), administered in arm right, administration date 22Oct2021 (Batch/Lot number: unknown) for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE: 2, Batch/Lot No: EN8732, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 29Mar2021, when the patient was 70 years old, for COVID-19 Immunization; Bnt162b2 (DOSE: 1, Batch/Lot No: EN6203, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 08Mar2021, when the patient was 70 years old, for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 22Oct2021, outcome "recovered" (Oct2021), described as "Slightly sore arm the first day". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Breast cancer left breast.  Abnormal mammogram in January of 2022.  Now undergoing surgery and additional treatment for invasive lobular carcinoma of the left breast.  Ever since I received those shots, I have become a shell of a person I used to be and I am convinced that putting those shots into my left arm led to breast cancer in the same side breast.
Redness, skin lifted as in a hive, itching, warm area - advised by MD 2 days later to just apply ice to area. Please note the handouts received were for "Meningococcal ACWY Vaccines - MenACWY and MPSV4", "Tdap Vaccine", "Influenza (Flu) Vaccine (Inactivated or Recombinant)" What you Need to Know. The exact type of shot given is unknown to me- above Vaccine selected might be incorrect.
I woke up later that night and had no strength in my arms or legs. It was nearly impossible to push myself to a sitting position so I could stand up to use the bathroom.
Arm was swollen, fever, nausea, "cloudy mind", headache, weakness, fatigue; lasting at least 4 days
patient complained of reduced range of motion 6 hours after receiving her first vaccine and has still persisted 28 days later. The decrease mainly consists of poor internal radial
Upset stomach, fatigue, body aches, malaise. Soreness in left arm down to 'bone'. Feverish throughout the day, duration of side effects have lasted for up to 1 week. Nausea the next day. Headache and some vertigo like symptoms for next three days after vaccine. Ibuprofen was taken to help with aches
Subsequently the pt was exposed to varicella. On June 7, 1999, the pt developed approximately twelve to fifteen skin lesions which started on his back and spread to his face and chest.
R09.02 HYPOXEMIA 1/23/2023 ATRIAL FIBRILLATION, UNSPECIFIED R09.02 HYPOXEMIA 1/23/2023 ASTHMA, UNSPECIFIED
Complaining her stomach hurt right after the Gardasil shot was administered then her face turned white she passed out her eyes rolled up into the back of her head her jaw was locked to the side she had incontinence at this time.
no adverse effects; patient received improperly stored PROQUAD; This spontaneous report was received from a registered nurse and refers to a 4-year-old male patient.     The patient's pertinent medical history, drug reactions, allergies were not reported.  On 13-MAY-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) rHA, lot # R030800, expiration date on 22-APR-2020 (strength, dose and route of administration were not reported) for prophylaxis. It was reported that the vaccine was exposed to a temperature -9 degrees Celsius to 8 degrees Celsius (-7.4 degrees Celsius) for 4 hours. There was no previous temperature excursion. Data logger was involved. Measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was reconstituted with properly stored sterile diluent (lot number R007087, expiration date on 20-JAN-2021). No product quality complaint (PQC) was associated with this report. No adverse effects were reported.
Patient had Typhoid vaccination this a.m. about 1000, IM with nausea and general malaise.  She has pain in the RIGHT shoulder with some tingliing in the RIGHT arm and hand.  No previous vaccination.  Had previous RIGHT shoulder surgery but the symptoms are new.  Physical exam Right deltoid region very tender.  Member looks ill.  Member feels she is able to continue to participate this UTA.
The 1st one no side effects besides sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (The 1st one no side effects besides sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (The 1st one no side effects besides sore arm). At the time of the report, PAIN IN EXTREMITY (The 1st one no side effects besides sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Patient experienced no side effects besides sore arm after the first dose of vaccine Treatment information was not provided.   This case was linked to MOD-2021-220986 (Patient Link).
Patient received Moderna covid vaccine, and shortly after became lightheaded.  Client lied on the floor, applied a cool compress to back of neck. Client was able to sit up shortly after, and was able to leave home. No further treatment required.
Dizzy, nausea, vertigo, headache and pain in right eye - reported by pt on 2/1/14. On 2/17/14 pt called clinic, reporting pressure behind right eye on 2/19/14 pt had appointment with PCP and pt reports blurred vision, fever, vertigo vomiting 2 hrs after tdap. 4 hrs post tdap -> pressure behind (R) eye, scotomata. Pt has appointment with ophthalmologist on 2/19, referred to neuroophthalmologist.
Pt recvd vax & exp muscle soreness & aches, stiff, joints for 5 wks in ankles,hips, wrists, neck;
Vaccines administered right deltoid 9/11/09. 9/12/09 developed red indurated area. Office visit on 9/14/09-induration approx. 3 cm in diameter, skin pink, no infection.
Probable cellulitis following vaccine. Persistent cyst/lump 2 months after event (ie drainage planned).
2nd Dose administered beyond 30-day use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd Dose administered beyond 30-day use) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd Dose administered beyond 30-day use). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (2nd Dose administered beyond 30-day use) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication reported. No concomitant medication reported. The vail Date taken out of freezer: 9/8/2021
pt stated that she had a sore arm and trouble sleeping.  Pt contacted her PCP about not being able to sleep so she was given a RX for Trazodone 50mg but pt is concerned about taking it due to the side affects.
Recieved call from school nurse reporting left arm swollen and sore. Child was sent home with fever and vomiting also.
This spontaneous report as received from a registered nurse reported that an unspecifed number of patients (ages and genders not reported) were vaccinated on unspecified dates with a dose of PEXVAX "over the last 5 years" that were exposed to temperature excursions outside of te proper storage range. No adverse effects were reported.  This is one of several reports received from the same source.  All telephone attempts to obtain follow-up information have been unsuccessful. Addiitonal information has been requested.
she was extremely exhausted; stuffed nose; On 28Feb2021, she took a swab test and got positive for COVID-19/ got tested for the COVID-19 Virus and tested positive/ tested positive again for the COVID-19 Virus; lost her smell/ Loss of smell; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202, expiration date: 30Jun2021), via an unspecified route of administration in left arm on 26Feb2021 at 14:00 at single dose for COVID-19 immunization. The relevant medical history included thyroid disease (had Thyroid Disease for 20 years) from an unspecified date and ongoing. Concomitant medications were reported as none. The patient said she lost her smell on 27Feb2021. She said her loss of smell was the only thing that had happened after she received her COVID-19 Vaccine. On 28Feb2021, she took a swab test and got positive for COVID-19. She said she got tested on 01Mar2021 for the COVID-19 Virus and tested positive. She clarified she had a nasal swab test for the COVID-19 Virus done on 01Mar2021 and was notified she was COVID-19 Virus positive at 5:00PM on 04Mar2021. She said she never had a fever. She said she was extremely exhausted and had a stuffed nose. She said she had no coughing, and her breathing was good. She said she didn't lose her taste. She said her smell came back a week later. She said she had no fatigue or diarrhea. She said she kept worrying about her oxygen levels during that time. She said she quarantined for 15 days. She said she tested positive again for the COVID-19 Virus on Saturday on 13Mar2021. She clarified she had a COVID-19 Virus Nasal Swab test done on 13Mar2021 and found out at the time of the report (16Mar2021) she was positive again for the COVID-19 Virus. Reported she believed she got the COVID-19 Virus from her first COVID-19 Vaccine. She needed to know when the COVID-19 Virus was coming out of her. She said she contacted her doctor, and her doctor told her she cannot take her second COVID-19 Vaccine shot this Friday (19Mar2021) since she tested positive for the COVID-19 Virus. The patient declined any treatment. No treatment received for the events. The patient underwent lab test included COVID-19 virus test showed positive (took a swab test and got positive for COVID-19) on 28Feb2021; positive on 01Mar2021; positive on 13Mar2021 (COVID-19 Virus Nasal Swab test done on 13Mar2021 and found out at the time of the report (16Mar2021) she was positive again). The outcome of the event lost her smell/ loss of smell was recovered on Mar2021, while other events were unknown.
No adverse events, however, pt didn't know she was 2 weeks pregnant when she received her #4 anthrax shot. She is concerned if there will be any side effects.
fever 104 24hr p/vax; eval in ER & tx w/meds & pt did well;
Pt developed a rash that afternoon after receiving the flu vaccine by, LPN. Was seen in clinic 01/14/2021. Dr. advised to use Zyrtec and Benadryl and refer to an allergist in the future.
Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     The patient's past medical history included Broken wrist and Lung lobectomy (Upper left lung lobe removed). Concurrent medical conditions included Trigeminal neuralgia, Sciatica, Chronic back pain and Lung cancer. Concomitant products included METHADONE, HYDROMORPHONE, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE (CYMBALTA) and TRAZODONE for an unknown indication.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 12-May-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not reported.   This case was linked to MOD-2021-235431 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: No new information received.
Information has been received from a medical assistant regarding a patient of unknown age and gender. On 07-NOV-2014 the patient was vaccinated with an expired dose of MMR II (lot # H018949, expiration date 18-OCT-2014) (dose and route not reported). No adverse effects were reported. It was unknown if the patient sought medical attention. Additional information is not expected because the reporter cannot be contacted.
I received my 2nd Covid vaccine the morning of Sept 1st,  that night I felt my arm was sore. I also felt the same achy feeling on my spine.  The next day my wrists started hurting, I had muscle aches and joint pains around my wrists.  This achy feeling in my wrists has continued.  A week or so later I started feeling the achy feeling up and down both of my arms. It felt like muscle tightness, sometimes its a burning feeling . About three weeks after I got the 2nd shot I got the scariest of my symptoms, My hands started trembling off and on. I tried typing something on my computer that day and my fingers were not doing what my brain was telling them to, they were clumsy and heavy. As I'm typing this my hands are shaking. I've never had any sort of neurological problems before this.  I've also woken up with cramps in my legs four times since the vaccine. I rarely get muscle cramps.
Information  has been received from a nurse practitioner concerning a 73 year old male with dyslipidaemia and a history of coronary artery disease, cardiac pacemaker insertion, hiatus hernia, right nephrectomy and renal cancer who on 21-Nov-2006 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot#651357/0391F), IM. Concomitant therapy included simvastatin, aspirin, digoxin, triamterene and desmopressin (DDAVF). On 21-Nov-2006, the patient developed pain in his right shoulder which radiated down his arm about 1-2 hours after vaccination with pneumococcal 23v polysaccharide vaccine. The pain progressed resulting in an inability to move his shoulder. The patient went to the emergency room (ER) ON 26-Nov-2006 and was admitted to the hospital the same day. The patient had orthoscopic surgery on his right shoulder to clean mucopurlent drainage from the shoulder joint. The patient received IV Vancomycin while in the hospital. The patient was discharged on 24-Nov-2006. The patient received daily antibiotics for one month. Pain in his right shoulder which radiated down his arm and inability to move shoulder were considered to be disabling, other important medical event and life threatening (OMIC). Additional information has been requested.
I noticed a knot later on that evening at  the injection site and arm became really sore. Woke up with chills and fever during the night. When I got up to get ready for work I had chills, nausea , body aches , headache and a fever. Just took my temp at 8:30 am and its 101.5
9/16/02 child presented at office today via mother. A raised "measle" like rash was noted from head to toe. Events as reported by mother: 9/12/03 temp 104.3 axillary. Child was afebrile yesterday 9/15/03. Child vomited large amount one time Friday evening. 9/13/03 child seen by pediatrician. MD noted wheezing at this time and swelling of scrotum. Slightly faint rash noted on face (across bridge of nose) and on trunk. 9/16/03 child seen by pediatrician again. Impression: viral exanthem. On physical examination had a little pharyngeal redness. The eyes were clear. He had just a mild end expiratory wheeze and a little faint blanching maculopapular type of rash on the trunk that was very faint. A chest x-ray was essentially clear at that time and his white count was 8.7 with a normal differential. Hemoglobin, hematocrit, and platelets were also normal. His differential was 55 polys, 4 bands, 40 lymphs and 1 eosinophil. His hemoglobin was around 10.3 so a little low with  hypochromic microcytic indices and a 241,000 platelet count. He was treated with just a little oral Alburerol and cautious observation. The temperature slowly came down but he had the temperature on the 13th and the 14th and then on the 14th he was seen in the ER with a little right scrotal swelling and was seen and evaluated by Dr. At that point in time he still had a temp of 103 and there were no signs of any hernia but he had a more florid type of rash. He was continued on symptomatic treatment. He presents today on 9/16/03 referred from the health office because of concerns about an MMR reaction as the cause of the rash. They called and are in the process of completing a VAER's report at this time. He was referred out here for clinical evaluation. Today his mother reports that he seems to be much better. His temperature is now down and he is afebrile. His activity and appetite are back to normal. He still has a bit of a cough but it is less so. In the interim he had a little loose stools but otherwise his bowel habits have been normal and there has been no bleeding of course. He has an episode of vomiting on Friday evening.
This spontaneous report was received from a healthcare worker and refers to 9 unspecified patients of unknown age and gender. The patients' medical histories and concurrent conditions were not reported. On an unknown dates, the patients were vaccinated with the improperly stored doses of (Merck) VARIVAX (Lot# L008271; expiration date 11-MAR-2017; dose and route of administration were not reported). No adverse effects were reported. Follow up information was received on 23-OCT-2015 from a certified medical assistant. The medical assistant noted that the number of patients who were vaccinated with improperly stored doses of (Merck) VARIVAX (Lot# L008271) was 8, not 9 as previously reported. Follow-up information has been received on 27-OCT-2015 from the certified medical assistant. The reporter provided that the patient of unknown age and gender was vaccinated with the improperly stored dose of (Merck) VARIVAX on 14-AUG02015. It was also reported that the vaccine was 1224 hours out of range. This is one of several reports received from the same reporter. Additional information has been requested. Patient, product and event details and analysis were updated.